PurpleStride is the signature event of the Pancreatic Cancer Action Network. Each year, in communities across the country, tens of thousands of people participate in more than fifty-six PurpleStride events, including PurpleStride Raleigh-Durham. These events are critical in raising awareness and funds that advance research and support patients and loved ones with a promise of … Continue reading Photos from Purple Stride 2016
Researchers extract cancer cells’ ‘deadly secrets’ at UNC Lineberger symposium
Researchers from around the country convened in Chapel Hill April 11-12 for UNC Lineberger’s Scientific Symposium to hear the latest research into molecularly targeted treatments for cancer. More than 440 people attended the symposium, the 40th annual, at The William and Ida Friday Center for Continuing Education. Called “Molecularly Targeted Cancer Therapies from Bench to Bedside,” … Continue reading Researchers extract cancer cells’ ‘deadly secrets’ at UNC Lineberger symposium
Join Us on Capitol Hill to Advocate for Increased Research Resources
Join participants from across the country – pancreatic cancer survivors, caregivers and volunteers – as we advocate for increased funding for pancreatic cancer research. It's time to tell Congress that together, we can make the impossible possible for patients everywhere!
UNC Lineberger researchers driven to fight pancreatic cancer
Kirsten Bryant, PhD, a cancer researcher and postdoctoral fellow at the UNC Lineberger Comprehensive Cancer Center, and Channing Der, PhD, a UNC Lineberger member and the Sarah Graham Kenan Professor of Pharmacology, shared personal stories of why they're driven to fight pancreatic cancer at a breakfast in Durham on Tuesday. See the full article here: https://unclineberger.org/news/unc-lineberger-researchers-driven-to-fight-pancreatic-cancer?utm_source=lineup&utm_medium=email&utm_campaign=10
Purple is the New Black
Dr. Channing Der and the rest of the lab were featured in an article on the Carolina Scientific blog. The article highlights the science the lab is developing as well as the motivation behind the work for many members of the lab. To see the full article visit the Carolina Scientific website here: http://www.carolinascientific.org/blog/2016/3/6/karriuinq0hkifsfj50nznalaiqxup The Carolina … Continue reading Purple is the New Black
Meagan Ryan Awarded AACR-Woman in Cancer Research Scholar Award
Meagan Ryan, graduate student in the Der and Cox Labs and CCBTP trainee, has been selected to receive a Women in Cancer Research (WICR) Scholar Award. These awards are given annually to WICR members who are scientists-in-training and presenters of meritorious scientific papers at the AACR Annual Meeting. Meagan will present her poster on "Inhibition … Continue reading Meagan Ryan Awarded AACR-Woman in Cancer Research Scholar Award
Channing Der Serves as Thesis Opponent
Dr. Channing Der served as a thesis opponent to Arafath Kaja Najumudeen today at the Abo Akademi University in Turku, Finland. Arafath completed his PhD studies on the Ras oncogene.
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found a promising strategy that may limit the growth of pancreatic cancers in patients with a mutation in a gene called KRAS. More than 95 percent of pancreatic cancers have KRAS mutations, and there's strong evidence that blocking the gene's function could be a very … Continue reading Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
Kirsten Bryant awarded Pathway to Leadership Grant
GRANTEE: KIRSTEN BRYANT, PHD University of North Carolina at Chapel Hill Research Project: Exploiting pancreatic cancer cell metabolism for therapeutic gain Award: 2015 Pancreatic Cancer Action Network – AACR Pathway to Leadership Grant Award Period: October 1, 2015 – September 30, 2020 Amount: $600,000 Biographical Highlights Dr. Bryant is currently a postdoctoral researcher in the laboratory … Continue reading Kirsten Bryant awarded Pathway to Leadership Grant
Cox and Der lead team to $2M+ NCI U01 grant
A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an NCI U01 grant on New Approaches to Synthetic Lethality for Mutant KRas-Dependent Cancers. Their team, which also includes Drs. Ben Major at UNC, Kris Wood … Continue reading Cox and Der lead team to $2M+ NCI U01 grant
